Medical Care

Global Movement Disorder Market Outlook with Ongoing Trends, Top Players Profile Analysis and Forecast 2017-2022

Growing prevalence of the neurological diseases is expected to contribute towards growth of the global movement disorder market. As manufacturers are increasingly focusing on development and innovation of products, growth of the global market is expected to remain positive. This Fact.MR report analyzes the expansion of global movement disorder market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026.

Request Free Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=329

The next section offers an overview of the global movement disorder market. This comprises an introduction to the market, along with a standard definition of the product – movement disorder. In this section, market value and year-over-year growth is offered to the readers. Year-over-year growth provides readers with a broader view of growth patterns over the forecast period.

The report’s succeeding section focuses on drivers, restraints and key trends from macroeconomic, demand, and supply perspectives. Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.

In order to offer readers with up-to-date information about the latest advancements in the global movement disorder market, the report provides updates about market opportunities, which can benefit leading manufacturers of movement disorder. With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for movement disorder manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided in this section.

FDA Approval to Boost Sales of Medications

Medications and treatments approved by FDA is also expected to impact growth of the global movement disorder market. Xadago (safinamide) tablets and Ingrezza capsules are two drugs that have recently cleared the FDA pipeline. Ingrezza capsules have recently received approval for treatment of dyskinesia and Xadago (safinamide) tablets have received approval of Parkinson’s disease. In addition, the FDA has also approved implantation of brain to reduce the tremor symptoms. These factors are further expected to boost growth of the global movement disorders market.

Advanced Features to Impact Growth of the Global Market

In order to gain a competitive edge, various companies operating in the global movement disorder market are focusing on product innovation and developments. Manufacturers are mainly concentrating on incorporating advanced technology in the medical devices for faster recovery and improved results. Equipped with the advanced features such as sensors, 360-degree stabilizing solutions and cloud technology. Parkinson’s spoon equipped with advanced technological features enable the end users to retrieve and store information regarding the status of the unwanted tremors and generates the algorithm of tremor patterns for optimal stabilization. Moreover, the manufacturers operating in the global market are offering the electronic stabilizing handle, which comprises everyday spoon, spork, soup spoon and a fork. Bound to these factors, the global movement disorders market is expected to witness significant growth during the forecast period.

Browse Full Report with TOC-https://www.factmr.com/report/329/movement-disorder-market

On the other hand, various factors continue to impact growth of the global movement disorders market negatively. Lack of investment in research and development will continue to inhibit growth of the global movement disorder market. In addition, slow approval of the medications developed is further likely to impact growth of the global market negatively. Moreover, poor method of therapeutics conducted continues to pose significant challenges towards growth of the global market.

Parkinson’s disease to Represent a Leading Segment

Growing need for medical devices with the uninterrupted functioning for treatment of the neurological disorders has led to an upsurge in adoption of rechargeable deep brain stimulator devices. On the basis of product type, the rechargeable deep brain stimulator devices segment is expected to generate significant revenues, accounting for a value of over US$ 500 Mn by the end of 2026. However, the non-rechargeable deep brain stimulator devices product type segment is expected to register the highest CAGR during the forecast period.

Based on end user, the hospitals segment is expected to represent the highest revenue growth, recording a value of less than US$ 100 Mn by the end of 2017. On the other hand, the clinics end user segment is expected to register a robust through 2026.

By application, the Parkinson’s disease segment is expected to represent a significant revenue growth, accounting for a value of over US$ 400 Mn by the end of 2026. In contrary to this, the dystonia application segment is expected to register a healthy CAGR throughout the forecast period.

Competition Tracking

Leading market players operating in the global movement disorder market include Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation and Mayo Clinic.

Check Discount- https://www.factmr.com/connectus/sample?flag=D&rep_id=329

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized  Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: [email protected]/
Web: https://www.factmr.com/